肩关节置换术中肌间沟臂丛阻滞联合或不联合术中脂质体布比卡因局部浸润:一项随机对照试验
78例初次肩关节置换患者随机分为肌间沟臂丛阻滞(ISBPB)联合Exparel组(39例)与单纯ISBPB组(39例),主要结局为术后24小时吗啡当量单位(MEU)消耗量。ISBPB组24小时MEU显著低于ISBPB+Exparel组(18.9±25.6 vs 35.3±36.7,p=0.009),术后72小时内VAS疼痛评分无显著差异。作者认为在包含ISBPB的镇痛方案中添加Exparel无明显价值。
要点
- ISBPB组术后24小时MEU为18.9±25.6,显著低于ISBPB+Exparel组的35.3±36.7(p=0.009)。
- 术后72小时内各时间点VAS疼痛评分两组间无显著差异。
- 作者认为在包含ISBPB的镇痛方案中添加Exparel无明显价值。
核心结论
- 接受Exparel治疗的患者术后需要显著更多的麻醉药品,且术后72小时内疼痛评分无显著降低。
- 作者认为在包含ISBPB的镇痛方案中添加Exparel无明显价值。
研究设计与样本
- 随机对照试验,78例接受初次肩关节置换的患者随机分为ISBPB+Exparel组(39例)和单纯ISBPB组(39例)。
- 主要结局为术后24小时消耗的吗啡当量单位(MEU);次要结局包括术中麻醉药品给药和术后0、8、16、24、48、72小时的VAS疼痛评分。
主要发现
- ISBPB组与ISBPB+Exparel组人口学特征无显著差异。
- 术后24小时总麻醉药品消耗量ISBPB组显著低于ISBPB+Exparel组(均值±标准差,18.9±25.6 MEU vs 35.3±36.7 MEU,p=0.009)。
- 术后72小时内各时间点VAS疼痛评分两组间无显著差异。
临床怎么用
- 作者认为在包含ISBPB的镇痛方案中添加Exparel无明显价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however, "rebound pain" can increase the patient's postoperative pain experience and narcotic usage. Exparel (liposomal bupivacaine) injected into the soft tissues at the surgical site has theoretical efficacy for up to 72 hours after administration. The purpose of this study was to evaluate postoperative pain scores and narcotic consumption following shoulder arthroplasty performed with either ISBPB alone or ISBPB and intraoperative Exparel. METHODS: Seventy-eight patients undergoing primary shoulder arthroplasty were randomized to receive an ISBPB with Exparel (39 patients) or without Exparel (39 patients). The primary outcome variable was morphine equivalent units (MEUs) consumed over the first 24 hours after surgery. Secondary outcomes included intraoperative narcotic administration and visual analog scale (VAS) scores for pain (at 0, 8, 16, 24, 48, and 72 hours after surgery). RESULTS: There were no significant demographic differences between the ISBPB and ISBPB + Exparel groups. Total narcotic consumption over the first 24 hours after surgery was significantly lower in the ISBPB group compared with the ISBPB + Exparel group (mean and standard deviation, 18.9 ± 25.6 MEU versus 35.3 ± 36.7 MEU, p = 0.009). VAS pain scores did not differ significantly between groups at any time point during the first 72 hours after surgery. CONCLUSIONS: Patients treated with Exparel required significantly more postoperative narcotics and demonstrated no significant reduction in pain scores over the first 72 hours after primary shoulder arthroplasty. Exparel does not appear to have substantial value when added to a pain protocol that includes an ISBPB. LEVEL OF EVIDENCE: Therapeutic Level l. See Instructions for Authors for a complete description of levels of evidence.
引用
- Namdari S, Nicholson T, Abboud J, et al. Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty: A Randomized Controlled Trial. J Bone Joint Surg Am. 2018. PMID: 30106818. doi:10.2106/JBJS.17.01416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。